Vivosim Lab Inc (VIVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,448 | -9,537 | -6,037 | -2,532 | -16,826 |
| Depreciation Amortization | 142 | 96 | 59 | 25 | 41 |
| Accounts receivable | N/A | 0 | N/A | N/A | 111 |
| Accounts payable and accrued liabilities | 134 | 324 | 677 | 296 | -439 |
| Other Working Capital | 597 | 1,100 | 1,581 | 679 | -2,113 |
| Other Operating Activity | 2,122 | 1,105 | 164 | 119 | 5,903 |
| Operating Cash Flow | $-8,453 | $-6,912 | $-3,556 | $-1,413 | $-13,323 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -409 | -356 | -223 | -194 | -393 |
| Investing Cash Flow | $-409 | $-356 | $-223 | $-194 | $-393 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 251 | 251 | 251 | 251 | 23,840 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -1 |
| Other Financing Activity | -46 | -46 | -45 | 0 | -4 |
| Financing Cash Flow | $205 | $205 | $206 | $251 | $23,835 |
| Beginning Cash Position | 37,475 | 37,475 | 37,475 | 37,475 | 27,356 |
| End Cash Position | 28,818 | 30,412 | 33,902 | 36,119 | 37,475 |
| Net Cash Flow | $-8,657 | $-7,063 | $-3,573 | $-1,356 | $10,119 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,453 | -6,912 | -3,556 | -1,413 | -13,323 |
| Capital Expenditure | -409 | -356 | -223 | -194 | -405 |
| Free Cash Flow | -8,862 | -7,268 | -3,779 | -1,607 | -13,728 |